Cassie D. Ostrander
Keine laufenden Positionen mehr
Profil
Cassie D.
Ostrander worked as a Principal at Corixa Corp., a Head-Media Relations at Immune Design Corp., and a Principal at Dharma Therapeutics, Inc. She received an undergraduate degree from Auburn University in 1981.
Ehemalige bekannte Positionen von Cassie D. Ostrander
| Unternehmen | Position | Ende |
|---|---|---|
Dharma Therapeutics, Inc.
 Dharma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Marduk Solution Co. Ltd., Dharma Therapeutics, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Seattle, WA. The company was founded by Steven G. Reed. The CEO is Paul R. Sleath. Dharma Therapeutics was acquired by Marduk Solution Co. Ltd. from Pine Capital Group Ltd. on April 21, 2014. | Corporate Officer/Principal | - |
| IMMUNE DESIGN CORP | Public Communications Contact | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | - |
Ausbildung von Cassie D. Ostrander
| Auburn University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Dharma Therapeutics, Inc.
Dharma Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Marduk Solution Co. Ltd., Dharma Therapeutics, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Seattle, WA. The company was founded by Steven G. Reed. The CEO is Paul R. Sleath. Dharma Therapeutics was acquired by Marduk Solution Co. Ltd. from Pine Capital Group Ltd. on April 21, 2014. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
